Ultima Genomics develops high-throughput DNA sequencing platforms designed to make large-scale genomic research more accessible and cost-effective. Its product lineup includes the UG 100 and UG200 Series sequencers, with the UG200 offering multiple wafer-output configurations and automated operation for high-volume sequencing. The company also provides library-preparation workflows, including Solaris 2.0, Solaris Free, Solaris Flex, and ppmSeq, alongside software and bioinformatics tools for analyzing sequencing data.

Ultima’s technologies support applications across germline research and whole-genome sequencing, oncology and minimal residual disease detection, methylation profiling, single-cell sequencing, proteomics, and RNA sequencing. Its analysis solutions include preconfigured pipelines and a dedicated high-performance server integrated with sequencing platforms. Customers can access the technology through certified service providers or Ultima’s Technology Access Program, which offers sequencing through an in-house applications laboratory with support from consultation to data analysis. Ultima also maintains an open, collaborative ecosystem compatible with third-party library-preparation providers and workflows, and offers scientific resources such as protocols, publications, datasets, technical notes, and application guides.